TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 20 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $4,420,000 | +15.5% | 19,200,435 | +79.4% | 0.01% | 0.0% |
Q4 2021 | $3,827,000 | +5.4% | 10,699,831 | +77.2% | 0.01% | 0.0% |
Q3 2021 | $3,630,000 | -54.6% | 6,038,664 | -16.2% | 0.01% | -50.0% |
Q2 2021 | $7,996,000 | -26.1% | 7,203,677 | -14.8% | 0.01% | -23.1% |
Q1 2021 | $10,822,000 | +5813.7% | 8,454,364 | +3017.8% | 0.01% | – |
Q4 2020 | $183,000 | -15.7% | 271,164 | -11.2% | 0.00% | – |
Q1 2020 | $217,000 | -42.1% | 305,532 | -4.6% | 0.00% | – |
Q4 2019 | $375,000 | – | 320,225 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtu Financial LLC | 734,477 | $441,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 516,218 | $310,000 | 0.03% |
Game Plan Financial Advisors, LLC | 27,216 | $16,000 | 0.01% |
MONECO Advisors, LLC | 35,000 | $21,000 | 0.01% |
Purus Wealth Management, LLC | 15,000 | $9,000 | 0.01% |
Renaissance Technologies | 6,038,664 | $3,630,000 | 0.01% |
Qube Research & Technologies Ltd | 540,878 | $325,000 | 0.00% |
D. E. Shaw & Co., Inc. | 6,690,867 | $4,022,000 | 0.00% |
Cutter & CO Brokerage, Inc. | 19,000 | $11,000 | 0.00% |
Van Hulzen Asset Management, LLC | 18,200 | $11,000 | 0.00% |